TCH346
From Self-sufficiency
Revision as of 17:04, 18 October 2009 by SmackBot (Talk) (Correct standard headers and general fixes)
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions may be available. (November 2006) |
TCH346 is a drug currently in clinical trials that is used to help treat Amyotrophic Lateral Sclerosis (ALS). Though this drug is still in testing, it is felt to be a work in progres, and it is widely thought that it will be a great advancement in medical sciences.
External Reference
- Neurological Institute of New York Columbia University
- National Center for Biotechnology Information article
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
